ABCG2基因单核苷酸多态性研究进展论文(5)
2013-09-27 01:04
导读：[16] KESKITALO J E,PASANEN M K,NEUVONEN P J, et al. Different effects of the ABCG2 c.421CA SNP on the pharmacokinetics of fluvastatin,pravastatin and simvastatin[J]. Pharmacogenomics,2009,10(10):1617-
[16] KESKITALO J E,PASANEN M K,NEUVONEN P J, et al. Different effects of the ABCG2 c.421C>A SNP on the pharmacokinetics of fluvastatin,pravastatin and simvastatin[J]. Pharmacogenomics,2009,10(10):1617-1624.
[17] CUSATIS G,GREGORC V,LI Jing,et al. Pharmaco-genetics of ABCG2 and adverse reactions to Gefitinib journal of the national cancer institute[J].J Natl Cancer Inst,2006,98(23):1739-1742.
[18] MORISAKI K,ROBEY R W,OZVEGY-LACZKA C, et al. Single nucleotide polymorphisms modify the transporter activity of ABCG2[J].Cancer Chemoth Pharm,2005,56(2):161-172.
[19] HAHN N M,MARSH S,FISHER W,et al. Hoosier oncology group randomized phase II study of docetaxel,vinorelbine,and estramustine in combination in hormone-refractory prostate cancer with pharmacogenetic survival analysis[J].Clin Cancer Res,2006,12(20):6094-6099.
[20] 王潇潇. BCRP基因的单核苷酸多态性研究：弥漫大B细胞性淋巴瘤的易感性发生存分析[D]. 广州：
中山大学，2007.
[21] 胡丽莉. MDRl及BCRP基因多态与肿瘤易感及预后的关系[D]. 广州：中山大学,2007.
[22] KIM D H,SRIHARSHA L,XU W,et al. Clinical relevance of a pharmacogenetic approach using multiple candidate genes to predict response and resistance to imatinib therapy in chronic myeloid leukemia[J].Clin Cancer Res,2009,15(14):4750-4758.
[23] WOODWARD O M,KZTTGEN A,CORESH J,et al. Identification of a urate transporter,ABCG2,with a common functional polymorphism causing gout[J].Proc Natl Acad Sci U S A,2009,106(25):10338-10342.
[24] GARDNER E R,AHLERS C M,SHUKLA S,et al. Association of the ABCG2 C421A polymorphism with prostate cancer risk and survival[J]. BJU Int,2008,102(11):1694-1699.
[25] MaLLER P,ASHER N,HELED M,et al. Polymorphisms in transporter and phase II metabolism genes as potential modifiers of the predisposition to and treatment outcome of de novoacute myeloid leukemia in Israeli ethnic groups[J].Leuk Res,2008,32(6):919-929.
（转载自http://zw.ＮＳＥaＣ.com科教作文网）
[26] hSTERGAARD M,ERNST A,LABOURIAU R,et al. Cyclooxygenase-2,multidrug resistance 1,and breast cancer resistance protein gene polymorphisms and inflammatory bowel disease in the Danish population[J].Scand J Gastroenterol,2009,44(1):65-73.
[27] CAMPA D,PARDINI B,NACCARATI A,et al. A gene-wide investigation on polymorphisms in the ABCG2/BCRP transporter and susceptibility to colorectal cancer[J].Mutat Res,2008,645(1-2):56-60.
[28] ANDERSEN V,OSTERGAARD M,CHRISTENSEN J,et al. Polymorphisms in the xenpbiotic transporter Multidrug Resistance 1(MDR1 ) and interaction with meat intake in relation to risk of colorectal cancer in a Danish prospective case-cohort study[J].BMC Cancer,2009,211(9):407.
